Company news

A spokesperson for GlaxoSmithKline told reporters that the company will make an announcement to US employees tomorrow about a reorganization, prompting press speculation about cuts to US-based sales forces.

Genzyme and Osiris Therapeutics have announced a partnership to develop and commercialize Prochymal and Chondrogen, two late-stage adult stem cell treatments. Osiris will commercialize the two treatments in the US and Canada, with Genzyme marketing the treatments in other countries.
You must be a registered member of MMM to post a comment.
close

Next Article in Channel

 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.